{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:46:24Z","timestamp":1747161984654,"version":"3.40.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.idnow.2024.104887","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T02:33:47Z","timestamp":1710470027000},"page":"104887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Significantly reduced duration of antibiotic prescription for erysipelas subsequent to the 2019 French guidelines on skin and soft tissue infection: A before-after study"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6868-4769","authenticated-orcid":false,"given":"Justin","family":"Destoop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9lia","family":"Vanhaecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8268-866X","authenticated-orcid":false,"given":"Firouz\u00e9","family":"Bani-Sadr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick","family":"Plenier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuelle-Anne","family":"Viguier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2729-9420","authenticated-orcid":false,"given":"Maxime","family":"Hentzien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2024.104887_b0005","unstructured":"Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Francaise et Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie. Conf\u00e9rence de consensus. Erysip\u00e8le et fasciite n\u00e9crosante\u00a0: prise en charge. Med Mal Infect. 2000;30:241\u20115."},{"issue":"2","key":"10.1016\/j.idnow.2024.104887_b0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.medmal.2017.01.007","article-title":"Proposal for shorter antibiotic therapies","volume":"47","author":"Wintenberger","year":"2017","journal-title":"M\u00e9decine et Maladies Infectieuses"},{"key":"10.1016\/j.idnow.2024.104887_b0015","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 [Internet]. [cit\u00e9 16 ao\u00fbt 2022]. Prise en charge des infections cutan\u00e9es bact\u00e9riennes courantes. Disponible sur: https:\/\/www.has-sante.fr\/jcms\/c_2911550\/fr\/prise-en-charge-des-infections-cutanees-bacteriennes-courantes."},{"key":"10.1016\/j.idnow.2024.104887_b0020","doi-asserted-by":"crossref","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 15 mars 2011;173(6):676\u201182.","DOI":"10.1093\/aje\/kwq433"},{"issue":"7198","key":"10.1016\/j.idnow.2024.104887_b0025","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/bmj.318.7198.1591","article-title":"Risk factors for erysipelas of the leg (cellulitis): case-control study","volume":"318","author":"Dupuy","year":"1999","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.idnow.2024.104887_b0030","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/archinternmed.2011.29","article-title":"Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscess","volume":"171","author":"Jenkins","year":"2011","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.idnow.2024.104887_b0035","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1086\/423960","article-title":"Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study","volume":"39","author":"Capelastegui","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idnow.2024.104887_b0040","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/jac\/dkm088","article-title":"Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced","volume":"59","author":"Meyer","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"15","key":"10.1016\/j.idnow.2024.104887_b0045","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","article-title":"Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis","volume":"164","author":"Hepburn","year":"2004","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.idnow.2024.104887_b0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/030006059101900602","article-title":"Azithromycin erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues","volume":"19","author":"Daniel European Azithromycin Study Group","year":"1991","journal-title":"J Int Med Res"},{"issue":"2","key":"10.1016\/j.idnow.2024.104887_b0055","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1128\/AAC.03688-14","article-title":"Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections","volume":"59","author":"Shorr","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idnow.2024.104887_b0060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.medmal.2019.07.005","article-title":"Impact of the French infectious diseases society\u2019s (SPILF) proposals for shorter antibiotic therapies","volume":"49","author":"Macheda","year":"2019","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.idnow.2024.104887_b0065","doi-asserted-by":"crossref","unstructured":"Moussaoui RE, De Borgie CAJM, Van Den Broek P, Hustinx WN, Bresser P, Van Den Berk GEL, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ. 10 juin 2006;332(7554):1355.","DOI":"10.1136\/bmj.332.7554.1355"},{"issue":"10","key":"10.1016\/j.idnow.2024.104887_b0070","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/jac\/dkt177","article-title":"Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection\u2014 7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials","volume":"68","author":"Eliakim-Raz","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.idnow.2024.104887_b0075","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cmi.2019.09.019","article-title":"Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial","volume":"26","author":"Cranendonk","year":"2020","journal-title":"Clin Microbiol Infect"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991924000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991924000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T08:11:44Z","timestamp":1713341504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991924000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2666991924000423"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2024.104887","relation":{},"ISSN":["2666-9919"],"issn-type":[{"type":"print","value":"2666-9919"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significantly reduced duration of antibiotic prescription for erysipelas subsequent to the 2019 French guidelines on skin and soft tissue infection: A before-after study","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2024.104887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104887"}}